% | $
Quotes you view appear here for quick access.

Endocyte, Inc. Message Board

  • The fact that Merck hasn't bought EYCT or made an official offer is a bit concerning considering they formed a partnership, and given how low ECYT is trading. Could be that ECYT wouldn't sell at the reduced levels, but it has to make you skeptical that Merck isn't interested in buy them for say $15 which most shareholders would feel is too low a price. It makes all the sense in the world for Merck to buy them out so I'm a little concerned that they haven't so far.

2.82-0.20(-6.62%)4:00 PMEST